Myxoid/round cell liposarcoma
MONDO:0020561Myxoid/round cell liposarcoma (MRCLS) is a type of liposarcoma (LS) mostly located in the limbs, with a variable behavior depending on the histological subtype. Both myxoid and round cell are distinct histological subtypes of LS.
Also known as: MRCLS, myxoid/round-cell liposarcoma
2831 clinical trials for this condition and its sub-types, 13 tagged with Myxoid/round cell liposarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Myxoid/round cell liposarcoma
-
Myxoid liposarcoma 15 trials
1 sub-type
- Ovarian myxoid liposarcoma 0 trials
-
Round cell liposarcoma 3 trials
-
Can a new drug shrink advanced solid tumors?
Disease control Recruiting nowThis trial tests an experimental drug called DS-2243a in adults with advanced solid tumors, including sarcoma, that have spread or cannot be removed surgically. The study has two parts: first, researchers find the safest dose by giving increasing amounts to small groups; then, th…
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Experimental drug aims to revive failing cancer fighters in rare sarcomas
Disease control Recruiting nowThis early-phase trial tests an immunotherapy drug called N-803 in up to 8 people with synovial sarcoma or myxoid/round cell liposarcoma whose cancer got worse after a prior cell therapy. N-803 is designed to boost the patient's own immune cells that survived the earlier treatmen…
Early phase 1 • Sponsor: Seth Pollack • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Genetically modified NK cells take on rare sarcomas in early trial
Disease control Recruiting nowThis early-phase trial tests a new therapy for people with advanced synovial sarcoma or myxoid/round cell liposarcoma. Participants receive donated natural killer (NK) cells that have been engineered to recognize and attack a protein called NY-ESO-1 found on their cancer cells. T…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Experimental virus vaccine takes on multiple cancers in early trial
Disease control Recruiting nowThis early-phase trial is testing a new virus-based cancer vaccine (PeptiCRAd-1) combined with the immunotherapy drug pembrolizumab in 15 people with various solid tumors like melanoma, triple-negative breast cancer, and lung cancer. The main goal is to see if the combination is …
Phase 1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC